10x Genomics
272 hedge funds and large institutions have $1.5B invested in 10x Genomics in 2024 Q4 according to their latest regulatory filings, with 62 funds opening new positions, 89 increasing their positions, 92 reducing their positions, and 49 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
31% less call options, than puts
Call options by funds: $1.4M | Put options by funds: $2.02M
36% less capital invested
Capital invested by funds: $2.36B → $1.5B (-$853M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
272
Holding in Top 10
–
Calls
$1.4M
Puts
$2.02M
Top Buyers
| 1 | +$51.8M | |
| 2 | +$28.9M | |
| 3 | +$19.2M | |
| 4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$18.8M |
| 5 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$15.8M |
Top Sellers
| 1 | -$48.8M | |
| 2 | -$40.3M | |
| 3 | -$27.8M | |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$21.5M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$12.2M |